Key result
Baseline depressive symptoms linked to ~8% higher incident chronic obstructive lung disease risk per PHQ-9 point.
Why the study?
Depression has been associated with specific somatic diseases as the leading cause of death, but prospective prediction of incident chronic diseases based on baseline depressive symptoms and sex-dependent effects was needed.
Do baseline depressive symptoms predict the incidence of common chronic diseases in a community sample?
Cohort (n=12,285)
No
Do baseline depressive symptoms predict the incidence of common chronic diseases in a community sample?
Baseline depressive symptoms are predictive of the incidence of several chronic diseases, including COPD and migraine, with a trend for cardiovascular disease, emphasizing the need for depression screening and lifestyle interventions.
Answers are grounded in this paper and cite their sources.
Depressive symptoms may flag higher chronic disease risk with sex differences; leaves open whether screening alters outcomes in community cohorts.
Background Depression, the most frequent and harmful mental disorder, has been associated with specific somatic diseases as the leading cause of death. The purposes of this prospective study were to predict incident chronic diseases based on baseline depressive symptoms and to test sex-dependent effects. Methods In a representative German community sample of over 12 000 participants, baseline depressive symptoms (assessed using the Patient Health Questionnaire-9) were tested as a predictor of new onset of cardiovascular disease (CVD), chronic obstructive lung disease, diabetes, cancer, and migraine at 5-year follow-up. To study disease incidence, we created subsamples for each chronic disease by excluding participants who already had the respective disease at baseline. Potential confounders were included in logistic regression models and sex-specific analyses were performed. Results Controlling for demographic characteristics and loneliness, in men and women, baseline depressive symptoms were predictive of CVD, chronic obstructive lung disease, diabetes, and migraine, but not of cancer. When we additionally adjusted for metabolic and lifestyle risk factors, there was an 8% increase of chronic obstructive lung disease and migraine per point of depressive symptoms. There was a trend for CVD (4%; p = 0.053). Sex-sensitive analyses revealed trends for the relevance of depressive symptoms for CVD in men (p = 0.065), and for diabetes in women (p = 0.077). Conclusions These findings underscore the need to implement screening for depression in the treatment of major somatic illnesses. At the same time, depressed patients should be screened for metabolic and lifestyle risk factors and for somatic diseases and offered lifestyle interventions.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Incident chronic diseases (CVD, chronic obstructive lung disease, diabetes, cancer, migraine) (n=12,285). Depressive symptoms (PHQ-9 score) vs. Lower depressive symptoms (per point increase) was evaluated on Incidence of chronic obstructive lung disease (OR 1.08, 95% CI 1.03-1.13, p=0.001). Baseline depressive symptoms predicted an 8% increased risk of incident chronic obstructive lung disease (OR 1.08) and migraine per point increase on the PHQ-9 over a 5-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: